The other cool thing is going from knowing nothing & no one at @SPARTAN_Updates@twitter.com in 2018 to chatting methods @Official_ASAS@twitter.com with @SteZhao@twitter.com @AlexSepriano@twitter.com & others

RT @rheum_cat@twitter.com

So cool to now be the one making introductions at an international meeting, instead of being the newest person there.

AND, to remember some of the debates of prior, pre-pandemic meetings.

#growth #ASAS2023

🐦🔗: https://twitter.com/rheum_cat/status/1613828196713070592

So cool to now be the one making introductions at an international meeting, instead of being the newest person there.

AND, to remember some of the debates of prior, pre-pandemic meetings.

#growth #ASAS2023

Our colleague from 🇮🇳 brings up the cost of generic #tofacitinib in India

#ASAS2023

Earlier discussion about the same:

https://twitter.com/BhattArshad/status/1589197908125323265?s=20&t=coCDFJ8I4o6GuczKxx0FRA

RT @BhattArshad@twitter.com

@docshri@twitter.com Biologics r freely available in India and biosimilars r lot cheaper than original ones. We also have Tofacitinib available in here and cost effective.
Lack of awareness is the issue so is the issue of lack of Rheumatologists.

🐦🔗: https://twitter.com/BhattArshad/status/1589197908125323265